Symbols

ENSC

Ensysce Biosciences·NASDAQ

--(--)

ENSC Profile

Ensysce Biosciences, Inc.

A clinical stage pharmaceutical company seeking to develop innovative solutions for severe pain relief while reducing the fear of and the potential for misuse, abuse, and overdose

Industry

Pharmaceutical

Established Date

Listing Date

07/02/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.ensysce.com

Security Type

Common stock

Office address

7946 Ivanhoe Avenue Suite 201 La Jolla California 92037

Business

Introduction

Ensysce Biosciences, Inc., was incorporated in Delaware in April 2003. The company is a clinical-stage pharmaceutical company dedicated to developing innovative solutions to relieve severe pain while reducing the risk of opioid misuse, abuse and overdose. The company is currently developing product candidates designed to improve the safety of prescription drugs.